Stephens Reaffirms “Overweight” Rating for Encompass Health (NYSE:EHC)

Stephens reissued their overweight rating on shares of Encompass Health (NYSE:EHC – Free Report) in a research note released on Tuesday morning, Benzinga reports. The firm currently has a $105.00 target price on the stock. Several other research analysts have also recently weighed in on EHC. Royal Bank of Canada lifted their price target on […]

Leave a Reply

Your email address will not be published.

Previous post Barclays Raises MercadoLibre (NASDAQ:MELI) Price Target to $2,100.00
Next post Lackluster investigations may perpetuate high Native infant mortality rate